LYMPHANGIECTASIA INTESTINAL side effect
What is LYMPHANGIECTASIA INTESTINAL ?Drugs associated with LYMPHANGIECTASIA INTESTINAL
PRANDINLYMPHANGIECTASIA INTESTINAL : Prandin Side Effects Report #5588083-7
Consumer or non-health professional from UNITED STATES reported PRANDIN problem on Jan 02, 2008. Male patient, 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with PRANDIN. After drug was administered, patient experienced the following problems/side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis, . PRANDIN dosage: .5 MG, TID. During the same period patient was treated with TRIAMTERENE, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient died.
LYMPHANGIECTASIA INTESTINAL : Prandin Side Effects Report #5379937-5
PRANDIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Male patient, 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with PRANDIN. After drug was administered, patient experienced the following problems/side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis, . PRANDIN dosage: .5 MG, TID. During the same period patient was treated with TRIAMTERENE, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient died.
LYMPHANGIECTASIA INTESTINAL : Prandin Side Effects Report #5379937-5
Consumer or non-health professional from UNITED STATES reported PRANDIN problem on June 25, 2007. Male patient, 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with PRANDIN. After drug was administered, patient experienced the following problems/side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis, . PRANDIN dosage: .5 MG, TID. During the same period patient was treated with TRIAMTERENE, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient died.